XDL
5156
XOXNET
0140
SCABLE
5170
ALRICH
0079
ANEKA
0226
MY Stock MarketDetailed Quotes
7081 PHARMA
- 0.355
- -0.005-1.39%
15min DelayNot Open Dec 20 16:53 CST
511.64MMarket Cap5.46P/E (TTM)
0.365High0.355Low697.20KVolume0.355Open0.360Pre Close250.43KTurnover0.47052wk High0.15%Turnover Ratio1.44BShares0.29552wk Low0.065EPS TTM164.45MFloat Cap1.267Historical HighLossP/E (Static)463.23MShs Float0.067Historical Low-0.059EPS LYR2.78%Amplitude--Dividend TTM-2.93P/B100Lot Size--Div YieldTTM
PHARMA Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -6.10%884.53M | 4.19%910.77M | 17.31%812.5M | -4.02%3.4B | -15.53%894.83M | 4.55%942M | 14.35%874.14M | -15.68%692.59M | -29.63%3.55B | 9.34%1.06B |
| Revenue from customers | -6.10%884.53M | 4.19%910.77M | 17.31%812.5M | -4.02%3.4B | -15.53%894.83M | 4.55%942M | 14.35%874.14M | -15.68%692.59M | -29.63%3.55B | 9.34%1.06B |
| Cash paid | 9.20%-862.78M | -19.27%-892.43M | -14.41%-846.77M | 9.19%-3.28B | 22.54%-838.13M | -11.47%-950.25M | 15.39%-748.24M | 6.27%-740.09M | 27.96%-3.61B | -19.14%-1.08B |
| Payments to suppliers for goods and services | 9.20%-862.78M | -19.27%-892.43M | -14.41%-846.77M | 9.19%-3.28B | 22.54%-838.13M | -11.47%-950.25M | 15.39%-748.24M | 6.27%-740.09M | 27.96%-3.61B | -19.14%-1.08B |
| Direct dividend paid | ||||||||||
| Direct dividend received | ||||||||||
| Direct interest paid | 14.86%-13.76M | -52.38%-22.94M | -22.18%-16.78M | -47.29%-60.81M | -210.60%-15.86M | -14.65%-16.17M | -25.46%-15.06M | -36.23%-13.73M | -26.53%-41.29M | 41.27%-5.11M |
| Direct interest received | 148.04%888K | 256.16%520K | -32.13%450K | 62.31%1.48M | 30.25%310K | 184.13%358K | -33.64%146K | 103.37%663K | -40.25%910K | -57.73%238K |
| Direct tax refund paid | -175.65%-9.66M | -92.14%-4.25M | 5.42%-4.8M | 48.25%-20.56M | -281.01%-9.77M | 68.16%-3.5M | 84.00%-2.21M | 58.85%-5.07M | 37.70%-39.73M | 94.32%-2.57M |
| Operating cash flow | 97.16%-783K | -107.66%-8.33M | 15.61%-55.39M | 132.99%46.95M | 204.28%31.38M | -217.13%-27.56M | 174.76%108.77M | -774.88%-65.64M | -122.21%-142.34M | -506.79%-30.09M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 59.04%-6.03M | -6.26%-5.93M | -181.53%-7.27M | 2.72%-57.6M | -105.15%-34.72M | -31.65%-14.72M | 51.79%-5.58M | 86.78%-2.58M | -96.21%-59.21M | -14.44%-16.92M |
| Net intangibles purchase and sale | 57.91%-1.14M | -29.31%-3.47M | 37.48%-1.3M | 43.75%-10.34M | 67.37%-2.87M | 37.69%-2.71M | -21.14%-2.68M | 31.35%-2.08M | -22.76%-18.38M | 37.02%-8.79M |
| Net investment product transactions | --618K | --40K | ---6.54M | --0 | --0 | --0 | --0 | --0 | 1,370.46%5.25M | 7,847.54%4.73M |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Investing cash flow | 62.41%-6.55M | -13.26%-9.35M | -224.23%-15.11M | 6.08%-67.93M | -79.11%-37.59M | -16.25%-17.43M | 39.89%-8.26M | 79.40%-4.66M | -58.78%-72.34M | 27.14%-20.99M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 117.70%10.45M | 99.89%-143K | -70.48%24.84M | -93.72%19.52M | -33.58%57.81M | 308.74%4.8M | -198.83%-127.23M | -13.71%84.14M | 70.30%310.98M | 87.88%87.04M |
| Net common stock issuance | ---- | ---- | ---- | --45.86M | --0 | ---- | ---- | ---- | --0 | --0 |
| Increase or decrease of lease financing | 17.30%-1.93M | 34.77%-1.65M | 38.59%-1.49M | -59.36%-12.04M | -18.10%-4.76M | -14.89%-2.33M | -149.90%-2.53M | -396.52%-2.42M | -162.40%-7.56M | -70.42%-4.03M |
| Cash dividends paid | ---- | ---- | ---- | 90.48%-7.86M | --0 | 99.71%-30K | --30K | ---7.86M | -40.01%-82.53M | 75.00%-6.55M |
| Cash dividends for minorities | ---49K | ---- | ---- | -113.13%-211K | --0 | --0 | ---- | ---- | -125.00%-99K | --0 |
| Net other fund-raising expenses | ---- | ---- | ---- | --50M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | -82.45%8.48M | 98.47%-1.99M | -68.38%23.35M | -56.85%95.27M | 34.77%103.05M | 426.18%48.3M | -309.17%-129.94M | -23.87%73.86M | 82.87%220.79M | 330.40%76.46M |
| Net cash flow | ||||||||||
| Beginning cash position | 117.00%60.27M | 41.41%80.07M | 141.14%127.44M | 12.18%52.85M | 9.47%30.73M | -19.78%27.77M | -56.86%56.62M | 12.18%52.85M | 31.37%47.11M | -42.23%28.07M |
| Current changes in cash | -65.56%1.14M | 33.13%-19.68M | -1,425.07%-47.15M | 1,113.21%74.29M | 281.38%96.84M | 152.74%3.31M | 69.70%-29.43M | -95.77%3.56M | -44.96%6.12M | 797.61%25.39M |
| Effect of exchange rate changes | -139.94%-859K | -120.55%-119K | -207.01%-229K | 179.53%307K | 79.12%-128K | -28.32%-358K | 14.88%579K | 10,600.00%214K | -408.80%-386K | -128.35%-613K |
| End cash Position | 97.06%60.55M | 117.00%60.27M | 41.41%80.07M | 141.14%127.44M | 141.14%127.44M | 9.47%30.73M | -19.78%27.77M | -56.86%56.62M | 12.18%52.85M | 12.18%52.85M |
| Free cash flow | 82.40%-7.95M | -118.48%-17.74M | 9.38%-63.96M | 87.86%-26.71M | 87.64%-6.9M | -666.48%-45.21M | 160.26%95.98M | -449.70%-70.58M | -101.05%-219.97M | -159.70%-55.83M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.